Renaissance Technologies
NDRA icon

Renaissance Technologies’s ENDRA Life Sciences NDRA Stock Holding History

Renaissance Technologies’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed -$11K – 3993
2023
Q3 		$11K Hold
6
– – ﹤0.01% 3577
2023
Q2 		$15K Buy
+6
New +$16.9K ﹤0.01% 3803
2022
Q4 		– Sell
-8
Closed -$86K – 4304
2022
Q3 		$86K Sell
8
-8
-50% -$82.6K ﹤0.01% 3640
2022
Q2 		$132K Buy
16
+6
+60% +$53.7K ﹤0.01% 3771
2022
Q1 		$136K Buy
10
+4
+67% +$71.7K ﹤0.01% 3736
2021
Q4 		$150K Buy
+6
New +$255K ﹤0.01% 3607
2021
Q1 		– Sell
-2
Closed -$65K – 3579
2020
Q4 		$65K Buy
+2
New +$53.4K ﹤0.01% 3303
2020
Q3 		– Sell
-1
Closed -$18K – 3574
2020
Q2 		$18K Buy
+1
New +$29K ﹤0.01% 3374

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VNA
Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's NDRA Position: Q4 2023 in Review

Renaissance Technologies sold out of ENDRA Life Sciences (NDRA) in Q4 2023, closing a stake of 6 shares — an estimated $11K sold.

Renaissance Technologies first reported a position in NDRA in Q2 2020 and held it in 8 quarters. The position peaked at $150K in Q4 2021. 5 funds tracked by Wall St. Rank hold NDRA as of Q4 2023.

  • Renaissance Technologies reported no remaining ENDRA Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 6 ENDRA Life Sciences shares in Q4 2023, an estimated $11K.
  • Renaissance Technologies first reported a position in ENDRA Life Sciences in Q2 2020 and held it in 8 quarters.
  • Renaissance Technologies's ENDRA Life Sciences position peaked at $150K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.